title: Inhibition of human immunodeficiency virus type I integrase by naphthamidines and 2-aminobenzimidazoles.
authors.affiliation: Department R47D, Global Pharmaceutical Research and Development, Abbott Laboratories, 200 Abbott Park Rd., Abbott Park, IL 60064-6217, USA. timothy.middleton@abbott.com
authors.forename: Tim
authors.initials: T
authors.lastname: Middleton
authors.forename: Hock B
authors.initials: HB
authors.lastname: Lim
authors.forename: Debra
authors.initials: D
authors.lastname: Montgomery
authors.forename: Todd
authors.initials: T
authors.lastname: Rockway
authors.forename: Hua
authors.initials: H
authors.lastname: Tang
authors.forename: Xueheng
authors.initials: X
authors.lastname: Cheng
authors.forename: Liangjun
authors.initials: L
authors.lastname: Lu
authors.forename: Hongmei
authors.initials: H
authors.lastname: Mo
authors.forename: William E
authors.initials: WE
authors.lastname: Kohlbrenner
authors.forename: Akhteruzzaman
authors.initials: A
authors.lastname: Molla
authors.forename: Warren M
authors.initials: WM
authors.lastname: Kati
mesh_terms: D001483:Base Sequence; D001562:Benzimidazoles / Q000737:chemistry / Q000494:pharmacology*; D002460:Cell Line; D004279:DNA, Viral / Q000235:genetics; D005814:Genes, Viral; D019427:HIV Integrase / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D019428:HIV Integrase Inhibitors / Q000737:chemistry / Q000145:classification / Q000494:pharmacology*; D015497:HIV-1 / Q000187:drug effects* / Q000201:enzymology* / Q000235:genetics; D006801:Humans; D066298:In Vitro Techniques; D015394:Molecular Structure; D009281:Naphthalenes / Q000737:chemistry / Q000494:pharmacology*; D011994:Recombinant Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism
chemical_list: D001562:Benzimidazoles; D004279:DNA, Viral; D019428:HIV Integrase Inhibitors; D009281:Naphthalenes; D011994:Recombinant Proteins; D019427:HIV Integrase